{
  "id": 2577536,
  "title": "Is Tempus AI Stock a Buy After Its 75% Rally? Here's What to Know as the Firm's Legal Chief Files a Trade",
  "url": "https://urgent.news/2026/08/22/is-tempus-ai-stock-a-buy-after-its-75-rally-heres-what-to-know-as-the",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-22T12:05:25.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/coverage/filings/2026/08/22/is-tempus-ai-stock-a-buy-after-its-75-rally-here-s-what-to-know-as-the-firm-s-legal-chief-files-a-trade/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": null,
  "summary": "Tempus AI, Inc. (NASDAQ:TEM), a healthcare technology firm based in Chicago with a market capitalization of $10.7 billion and 3,800 employees, has experienced a remarkable 75% rally in its stock price. However, the company's legal chief, Andrew Polovin, has recently sold 30,075 shares of the stock, totaling $1.5 million, according to an SEC Form 4 filing. The transaction value is based on a weighted average sale price of $51.29, while the post-transaction value is $61.25, based on the August 19 market close. Despite its impressive market valuation, Tempus AI remains unprofitable on a trailing twelve-month (TTM) basis, with a negative net income of $254.4 million, as it continues to invest in platform expansion and market penetration. Investors should carefully weigh the potential risks and rewards before considering this stock a buy.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "Is Tempus AI Stock a Buy After Its 75% Rally? Here's What to Know as the Firm's Legal Chief Files a Trade",
        "url": "https://urgent.news/2026/08/22/is-tempus-ai-stock-a-buy-after-its-75-rally-heres-what-to-know-as-the-2579360",
        "published": "2026-08-22T12:25:25.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}